Rajdev All News
Saturday, November 10, 2018
Coherus prices biosimilar to Amgen's Neulasta at 33 percent discount
Coherus BioSciences Inc said on Thursday it would price its biosimilar to Amgen Inc's infection-fighting treatment, Neulasta, at a 33 percent discount.
from Reuters: Health https://ift.tt/2qJmYzr
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment